Stalfort John A III

CIK 00017094184 companiesNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001709418

Recent Transactions

32 trades

Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-06-04+12,800→ 185,124 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2025-06-04+19,500→ 19,500 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2025-06-02+113,246→ 113,246 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-06-02+56,623→ 1,155,224 total
Gift
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-11-26+50,000→ 1,873,800 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series B Warrants (right to buy)
2024-11-22+561,797→ 561,797 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Series A Warrants (right to buy)
2024-11-22+561,797→ 561,797 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2024-11-22+1,123,595→ 1,823,800 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2024-06-10+25,000→ 25,000 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2024-05-29+98,440→ 98,440 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2024-05-29+49,220→ 1,098,601 total
Gift
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-08-16+50,000→ 1,049,381 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-08-16$0.90/sh+388,889→ 999,381 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-08-16$0.90/sh+388,889→ 884,290 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2023-06-22+43,800→ 43,800 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2023-06-06+25,000→ 25,000 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2022-07-05$2.10/sh+238,095→ 700,205 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2022-06-15+25,000→ 25,000 total
Purchase
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-07-06$16.00/sh+35,000→ 172,324 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Series B Preferred
2021-07-06−131,595→ 0 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-07-06+131,595→ 131,595 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-07-06+130,180→ 137,324 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Series A-1 Preferred
2021-07-06−130,180→ 0 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (Right to Buy)
2021-06-30+34,000→ 34,000 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2020-08-14$6.38/sh+15,700→ 462,110 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2020-08-13$6.45/sh+15,550→ 446,410 total
Disposition from Tender
Dova Pharmaceuticals Inc.
Common Stock
2019-11-12$27.50/sh−635,665→ 0 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2019-01-07$10.38/sh+8,021→ 429,660 total
Purchase
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2019-01-07$10.94/sh+1,200→ 430,860 total
Purchase
Dova Pharmaceuticals Inc.
Common Stock
2018-12-20$6.26/sh+31,000→ 635,665 total
Conversion
Verrica Pharmaceuticals Inc.$VRCA
Series A Convertible Preferred Stock
2018-06-19−394,295→ 0 total
Conversion
Verrica Pharmaceuticals Inc.$VRCA
Common Stock
2018-06-19+394,295→ 421,639 total

Companies

Recent Filings

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465

View on SEC.gov